Dashboard
Manage Tickers

OLMAOlema Pharmaceuticals, Inc.

Nasdaq olema.com


$ 11.53 $ 0.11 (0.96 %)    

Thursday, 29-Aug-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 471.89 $ -0.69 (-0.15 %)
DIA $ 413.95 $ 2.57 (0.62 %)
SPY $ 559.30 $ 0.05 (0.01 %)
TLT $ 97.51 $ -0.32 (-0.33 %)
GLD $ 232.94 $ 1.20 (0.52 %)
$ 11.55
$ 11.53 x 200
-- x --
-- - --
$ 8.51 - $ 17.79
271,551
na
661.43M
$ 1.98
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 03-11-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-09-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-10-2021 06-30-2021 10-Q
14 05-11-2021 03-31-2021 10-Q
15 03-17-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-overweight-on-olema-pharmaceuticals-lowers-price-target-to-31
JP Morgan Maintains Overweight on Olema Ph...
08/08/2024 16:23:24

JP Morgan analyst Anupam Rama maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Overweight and lowers the price target fr...

hc-wainwright--co-reiterates-buy-on-olema-pharmaceuticals-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Olem...
08/07/2024 20:19:48

HC Wainwright & Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and maintains $30 pri...

oppenheimer-reiterates-outperform-on-olema-pharmaceuticals-maintains-30-price-target
Oppenheimer Reiterates Outperform on Olema...
08/07/2024 17:59:07

Oppenheimer analyst Matthew Biegler reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Outperform and maintains $30 price...

olema-pharmaceuticals-q2-eps-054-beats-055-estimate
Olema Pharmaceuticals Q2 EPS $(0.54) Beats...
08/06/2024 20:39:44

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
06/04/2024 16:31:07

hc-wainwright--co-reiterates-buy-on-olema-pharmaceuticals-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Olem...
06/04/2024 11:02:20

HC Wainwright & Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and maintains $30 pri...

why-science-applications-international-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Science Applications International Sha...
06/03/2024 17:56:53

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/03/2024 16:31:06

stericycle-marinemax-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-monday
Stericycle, MarineMax, Agios Pharmaceutica...
06/03/2024 14:39:44

hc-wainwright--co-reiterates-buy-on-olema-pharmaceuticals-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Olem...
05/15/2024 17:58:39

HC Wainwright & Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and maintains $30 pri...

olema-oncology-announces-interim-results-from-phase-1b2-palazestrant-study-says-85-clinical-benefit-rate-observed-to-date-across-all-cbr-eligible-patients
Olema Oncology Announces Interim Results F...
05/15/2024 11:12:13

hc-wainwright--co-maintains-buy-on-olema-pharmaceuticals-raises-price-target-to-28
HC Wainwright & Co. Maintains Buy on Olema...
05/09/2024 19:31:28

HC Wainwright & Co. analyst Emily Bodnar maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and raises the price t...

olema-pharmaceuticals-q1-eps-056-misses-051-estimate
Olema Pharmaceuticals Q1 EPS $(0.56) Misse...
05/08/2024 21:05:59

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate ...

olema-pharmaceuticals-announced-that-it-will-present-new-clinical-data-from-the-companys-ongoing-phase-1b2-clinical-study-of-palazestrant-in-combination-with-cdk46-inhibitor-ribociclib-in-berlin-germany
Olema Pharmaceuticals Announced That It Wi...
05/08/2024 11:23:40

olema-pharmaceuticals-option-alert-oct-18-15-calls-at-the-ask-156--19-vs-1547-oi-earnings-514-after-close-est-ref1078
Olema Pharmaceuticals Option Alert: Oct 18...
05/03/2024 17:19:19

goldman-sachs-initiates-coverage-on-olema-pharmaceuticals-with-buy-rating-announces-price-target-of-24
Goldman Sachs Initiates Coverage On Olema ...
04/02/2024 11:09:16

Goldman Sachs analyst Richard Law initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy rating and announces ...

oppenheimer-reiterates-outperform-on-olema-pharmaceuticals-maintains-21-price-target
Oppenheimer Reiterates Outperform on Olema...
03/12/2024 12:18:02

Oppenheimer analyst Matthew Biegler reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Outperform and maintains $21 price...

hc-wainwright--co-maintains-buy-on-olema-pharmaceuticals-lowers-price-target-to-25
HC Wainwright & Co. Maintains Buy on Olema...
03/12/2024 10:39:57

HC Wainwright & Co. analyst Emily Bodnar maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price t...

olema-pharmaceuticals-q4-eps-049-misses-048-estimate
Olema Pharmaceuticals Q4 EPS $(0.49) Misse...
03/11/2024 20:04:08

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate ...

eaton-posts-strong-results-joins-ferrari-boot-barn-and-other-big-stocks-moving-higher-on-thursday
Eaton Posts Strong Results, Joins Ferrari,...
02/01/2024 15:46:02

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION